234 related articles for article (PubMed ID: 3410498)
21. Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation.
Ezeamuzie CI; Al-Hage M
Int Arch Allergy Immunol; 1998 Feb; 115(2):162-8. PubMed ID: 9482706
[TBL] [Abstract][Full Text] [Related]
22. Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats.
Akagi M; Kanoh R; Fukuishi N; Tachibana M; Akagi R
Arerugi; 1995 Mar; 44(3 Pt 1):182-8. PubMed ID: 7646374
[TBL] [Abstract][Full Text] [Related]
23. The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro.
Yukawa T; Read RC; Kroegel C; Rutman A; Chung KF; Wilson R; Cole PJ; Barnes PJ
Am J Respir Cell Mol Biol; 1990 Apr; 2(4):341-53. PubMed ID: 2322467
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
Zhang F; Decker K
Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
[TBL] [Abstract][Full Text] [Related]
25. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
Ezeamuzie CI; al-Hage M; Nwankwoala RN
Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
[TBL] [Abstract][Full Text] [Related]
26. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
Heuer H
Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
[No Abstract] [Full Text] [Related]
27. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
28. PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086.
Ukena D; Krogel C; Dent G; Yukawa T; Sybrecht G; Barnes PJ
Biochem Pharmacol; 1989 May; 38(10):1702-5. PubMed ID: 2543419
[No Abstract] [Full Text] [Related]
29. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
Kawaji K; Matsunaga Y; Kido H; Ogura T
Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
[TBL] [Abstract][Full Text] [Related]
30. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
31. Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils.
Kroegel C; Pleass R; Yukawa T; Chung KF; Westwick J; Barnes PJ
FEBS Lett; 1989 Jan; 243(1):41-6. PubMed ID: 2920824
[TBL] [Abstract][Full Text] [Related]
32. [Eosinophils in immediate allergic reactions].
Takizawa H
Nihon Rinsho; 1993 Mar; 51(3):664-8. PubMed ID: 8388063
[TBL] [Abstract][Full Text] [Related]
33. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
Johnson PR; Armour CL; Black JL
Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of cryptoporus polysaccharide on airway constriction, eosinophil release, and chemotaxis in guinea pigs.
Zhao XY; Xie QM; Chen JQ; Ke CK
Acta Pharmacol Sin; 2004 Apr; 25(4):503-7. PubMed ID: 15066221
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
36. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
38. Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles.
Tool AT; Koenderman L; Kok PT; Blom M; Roos D; Verhoeven AJ
Blood; 1992 May; 79(10):2729-32. PubMed ID: 1586719
[TBL] [Abstract][Full Text] [Related]
39. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils].
Kawashima T; Nagaki S; Iwakaji A; Iwamoto I; Yoshida S; Tomioka H
Arerugi; 1994 Dec; 43(11):1326-30. PubMed ID: 7887808
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis.
Sugimoto Y; Ogawa M; Tai N; Kamei C
Int Immunopharmacol; 2003 Jun; 3(6):845-52. PubMed ID: 12781701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
